Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis

OBJECTIVES: Hydroxychloroquine/chloroquine has been widely used as part of the standard treatment for patients with coronavirus disease 2019 (COVID-19). We conducted a systematic review and meta-analysis to determine whether hydroxychloroquine/chloroquine increases the risk of acute kidney injury (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Zheng-Ming, Zhang, Zhong-Min, Liu, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903764/
https://www.ncbi.nlm.nih.gov/pubmed/35253579
http://dx.doi.org/10.1080/0886022X.2022.2046609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903764/
https://www.ncbi.nlm.nih.gov/pubmed/35253579
http://dx.doi.org/10.1080/0886022X.2022.2046609

Ejemplares similares